Trial Profile
A Non-Randomized Multicenter Phase I/II Study Of Active Specific Immunotherapy In Patients With Stage II and Stage III Colon Cancer
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Autologous-cancer vaccine-Vaccinogen (Primary) ; Fluorouracil; Folinic acid
- Indications Colon cancer
- Focus Adverse reactions; Pharmacodynamics
- Sponsors Intracel Corporation
- 22 Aug 2014 New trial record